Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Heska Corporation of an aggregate principal amount of $86.25 million of its 3.750% convertible senior notes due 2026, including $11.25 million aggregate principal amount of notes sold pursuant to the initial purchasers’ exercise of their option to purchase additional notes.
Heska sells advanced veterinary diagnostic and specialty healthcare products. Its offerings include point of care diagnostics laboratory instruments and consumables, point of care digital imaging diagnostic products, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Heska’s core focus is on supporting veterinarians in the canine and feline healthcare space.
The Davis Polk corporate team included partner Alan F. Denenberg, counsel Jeffrey Gould and associates Xin (Anita) Guo and Benson Richards. Partner Rachel D. Kleinberg and associate Talya Presser provided tax advice. The intellectual property and technology team included associates Daniel F. Forester and S. Dream Montgomery. Members of the Davis Polk team are based in the Northern California and New York offices.